Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7VM3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,868
Award facts
- Contract value 100% obligated
- $24,867.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Zepbound 2.5 mg/0.5 ml pen injections. The contract is valued at $24,867.96 and utilizes firm fixed-price pricing with a completion date of January 30, 2026. This award represents a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, and its significant IDC with DLA enables efficient fulfillment of government requirements for essential pharmaceutical and medical commodities. This delivery order for Zepbound, a diabetes medication, reflects the company's ongoing role as a key supplier within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7VM3?
SPE2DR26F7VM3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F7VM3 worth?
The government has obligated $24,868 on SPE2DR26F7VM3.
Is contract SPE2DR26F7VM3 an order under another contract?
Yes. SPE2DR26F7VM3 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VM3 competed?
The extent of competition for SPE2DR26F7VM3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award